Literature DB >> 23657180

Acne vulgaris.

Annelise L Dawson1, Robert P Dellavalle.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23657180     DOI: 10.1136/bmj.f2634

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  22 in total

1.  Trends in the frequency of original research in acne vulgaris, rosacea, dermatitis, psoriasis, skin cancer, and skin infections, 1970-2010.

Authors:  Young M Choi; Jashin J Wu
Journal:  Perm J       Date:  2015

2.  Can oral isotretinoin be safely initiated and monitored in primary care? A case series.

Authors:  D Buckley; S Yoganathan
Journal:  Ir J Med Sci       Date:  2017-01-09       Impact factor: 1.568

Review 3.  Topical, Biological and Clinical Challenges in the Management of Patients with Acne Vulgaris.

Authors:  Anwar Al-Hammadi; Abla Al-Ismaily; Sameer Al-Ali; Rajesh Ramadurai; Rishi Jain; Lynn McKinley-Grant; Tariq I Mughal
Journal:  Sultan Qaboos Univ Med J       Date:  2016-05-15

4.  Teens and Technology Transforming Acne Treatment.

Authors:  Donna Lee Ettel; Lora Rose Lamanno; Sarah Anne Neyra; Wallace John Ettel; George Leonard Ettel; Matthew Kevin Mitchell
Journal:  Perm J       Date:  2017

5.  Bioavailability, Pharmacokinetics, and Transepidermal Water Loss of Short Contact Tazarotene Lotion 0.1% Versus Tazarotene (Tazorac®) Cream 0.1.

Authors:  Srinivas Sidgiddi; Kent Allenby; Franklin Okumu; Anirudh Gautam
Journal:  J Clin Aesthet Dermatol       Date:  2019-09-01

6.  Development and Investigation of Vitamin C-Enriched Adapalene-Loaded Transfersome Gel: a Collegial Approach for the Treatment of Acne Vulgaris.

Authors:  Sandhya Vasanth; Akhilesh Dubey; Ravi G S; Shaila A Lewis; Vivek M Ghate; Sally A El-Zahaby; Srinivas Hebbar
Journal:  AAPS PharmSciTech       Date:  2020-01-08       Impact factor: 3.246

7.  Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders.

Authors:  J G S Veit; Y Poumay; D Mendes; J Kreitinger; L Walker; A Paquet; C Menigot; F Zolezzi; A S Paller; P Diaz
Journal:  Skin Health Dis       Date:  2021-03-26

Review 8.  Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.

Authors:  Joachim G S Veit; Valérie De Glas; Benoît Balau; Haoming Liu; Florence Bourlond; Amy S Paller; Yves Poumay; Philippe Diaz
Journal:  J Invest Dermatol       Date:  2020-06-04       Impact factor: 8.551

9.  Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Authors:  Malene Plejdrup Hansen; Anna M Scott; Amanda McCullough; Sarah Thorning; Jeffrey K Aronson; Elaine M Beller; Paul P Glasziou; Tammy C Hoffmann; Justin Clark; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-18

Review 10.  Improving adherence to acne treatment: the emerging role of application software.

Authors:  Chanhyun Park; Gilwan Kim; Isha Patel; Jongwha Chang; Xi Tan
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.